Canadian Society of Autoimmune Diseases

06/17/2026

Histamine and autoimmune diseases are linked in a complex way. Histamine does not directly cause an autoimmune diseasebut she can aggravate certain symptoms and contribute to inflammation.

L’histamine et les maladies auto-immunes sont liées de façon complexe. L’histamine ne cause pas directement une maladie auto-immune, mais elle peut aggraver certains symptômes et participer à l’inflammation.

06/11/2026

Is it my menopause or an autoimmune disease? Symptoms can sometimes be difficult to differentiate!

What autoimmune diseases are often diagnosed around 45-50 years in women?



https://www.societecanadiennedesmaladiesautoimmunes.ca/blogues/3218484_menopause-versus-maladie-auto-immune?lang=en-US

06/09/2026

06/09/2026

No, autoimmune disease is not cancer but we sometimes have similar treatments for life and its side effects... a hope to calm the disease but no cure.

We don't have cancer but the announcement causes similar emotions: fear, uncertain future, shock, anxiety, guilt and exhaustion... a world that collapses and a physical and psychological fight... an important mental load!

If you really want to help, don't improvise doctors. Don't try to find the magic formula that doesn't exist style: celery juice and organic beetroot! 🤪

Your presence, listening and support are our flagship. Prepare us a meal, change our ideas! It's very simple! 🙏

06/03/2026

Viruses, bacteria, parasites: What are the triggers?

Une maladie auto-immune survient lorsque le système immunitaire attaque par erreur les tissus de son propre organisme.

05/27/2026

| 🔍🧬 A Canadian first in cell therapy against autoimmune diseases

Maisonneuve-Rosemont Hospital, a centre affiliated with the Université de Montréal, is the first Canadian site to participate in the Resolution international clinical trial that aims to evaluate allogeneic CAR-T therapy to treat refractory autoimmune diseases such as lupus, myositis and scleroderma.

Led by Drs. Nicolas Richard and Imran Ahmad, associate professors of clinic at the Department of Medicine of the UdeM, this project marks a promising advance in cell therapy and clinical research. A first patient has already been treated at the HMR as part of this phase I study.

📌 Learn more: link

https://bit.ly/4f9UrMQ

L’HMR lance un essai clinique pour évaluer une thérapie CAR-T allogénique en vue de traiter des maladies auto-immunes réfractaires comme le lupus, la myosite et la sclérodermie. Un premier patient a été traité à l’Hôpital Maisonneuve-Rosemont (HMR), affilié à l’Université de Montr...